Clinical Trial Update: A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression [Phase 2]

View source ↗

Summary

Phase 2 study evaluating different doses of BI 1358894 in combination with quetiapine for major depressive disorder; the trial has completed and results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• BI-1358894
• Quetiapine (quetiapine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Depressive Disorder, Major | Phase 2 | Status: COMPLETED | Results posted: 2025-03-06